By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Akashi Therapeutics (Formerly Known As Dart Therapeutics) 

20 Stockbridge Road
Suite 3
Gt Barrington  Massachusetts   01230  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Akashi Appoints Alka Batycky To Executive Vice-President, Portfolio Management And Operations 12/1/2016 11:59:05 AM
Patient Died in Akashi's Halted Trial 2/5/2016 11:18:23 AM
Akashi Halts DMD Clinical Trial, Third Company to Recently Have Problems With DMD Drug Trials 1/26/2016 6:59:20 AM
Akashi Therapeutics Reports Positive Clinical Data On HT-100 In Patients With Duchenne Muscular Dystrophy 6/18/2015 11:18:17 AM
Akashi Therapeutics Acquires Global Rights To Novel DMD Treatment From Tonus Therapeutics 9/15/2014 7:36:19 AM
Akashi Therapeutics Presents Positive Clinical Data On HT-100 In Patients With Duchenne Muscular Dystrophy 7/3/2014 6:06:50 AM
Akashi Therapeutics Receives Collective Funding Of $1.5 Million To Support HT-100 Clinical Development 7/3/2014 6:03:32 AM
Dart Therapeutics Changes Name To Akashi Therapeutics 6/24/2014 10:27:08 AM
Dart Therapeutics Initiates Study of HT-100 for Duchenne Muscular Dystrophy 7/15/2013 11:11:58 AM
Biovista and Dart Therapeutics Enter into Drug Repositioning Collaboration Targeting Duchenne Muscular Dystrophy 3/26/2013 9:54:37 AM
12
//-->